FDA approved yet another indication for pembrolizumab (Keytruda) to treat patients with recurrent, locally advanced or metastatic, squamous cell carcinoma of the esophagus (ESCC).
A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.
Approved by the FDA in September, this new drug serves as a first-line therapy for patients with particular metastatic non-small lung cancer.
Walgreens' new integrated support program aims to help patients with cancer manage the side effects of undergoing treatment. Here’s five things to know about it.
Patients with atrial fibrillation who have had cancer are less likely to see a cardiologist and less likely to fill anticoagulant prescriptions.
Oncology pharmacists have a challenging job caring for cancer patients.
A new study investigates whether PET scans can help guide treatment in patients with aggressive non-Hodgkin lymphomas.